Login / Signup

Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.

Elia GiganteMohamed BouattourJosé Ursic BedoyaHélène RegnaultMarianne ZiolEric AssenatValérie ParadisJulien CalderaroNathalie Ganne-CarriéKarine Bouhier-LeporrierGiuliana AmaddeoJean Charles Nault
Published in: United European gastroenterology journal (2023)
The combination of atezolizumab and bevacizumab showed signs of anti-tumor efficacy in patients with unresectable/metastatic cHCC-CCA.
Keyphrases
  • squamous cell carcinoma
  • locally advanced
  • small cell lung cancer
  • metastatic colorectal cancer
  • liver metastases